AiMorphous Health
Basel, Switzerland
AiMorphous Health specializes in innovative, AI-powered blood diagnostics aimed at predicting the risks of thrombosis and bleeding. Their groundbreaking blood test is designed to identify early biomarkers of thrombosis. By analyzing blood samples with high accuracy and precision, AiMorphous Health hopes to enable timely interventions and save lives from devastating cardiovascular events, marking a significant advancement in thrombosis prevention and management.
Company Info
- Founded
- 2022
- Website
- www.aimorphous.health/
Only accessible to MedStartr community members.
Join nowWhat do you think of AiMorphous Health?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.